This content is machine translated Hypertrophic cardiomyopathy Progress in gene therapy and future prospects Hypertrophic cardiomyopathy (HCM) is the most common genetic cardiomyopathy worldwide, affecting around 1 in 500 people. Current therapeutic interventions include lifestyle optimization, medications, septal reduction therapies and, rarely, heart transplantation.…
View Post 10 min This content is machine translated Hypertrophic cardiomyopathy (HCM) Genetics and risk stratification for sudden cardiac death. Hypertrophic cardiomyopathy (HCM) is the most common hereditary heart muscle disease. The clinical picture ranges from asymptomatic patients to manifest heart failure and sudden cardiac death (SCD). The mainstay of…
View Post 14 min This content is machine translated Basic sports medicine diagnostics for amateur athletes Imaging in athletes at cardiovascular risk. In contrast to competitive athletes, there are no generally applicable recommendations for amateur athletes regarding risk stratification for cardiovascular events. An algorithm proposed by the European Society for Cardiac Rehabilitation…
View Post 3 min This content is machine translated Cardiology Update Renal denervation as safe and effective hypertension control The cardiology seminar at Medidays focused on three topics: blood pressure control, myocardial disease, and triple therapy for atrial fibrillation (AF) and stenting. In the treatment of resistant hypertension, renal…
